{
    "nctId": "NCT06537752",
    "briefTitle": "A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients",
    "officialTitle": "A Multi-center, Prospective, Observational stuDy to Evaluate EThanOl-induced Symptoms and Safety in Breast Cancer Patients witH Neoadjuvant/Adjuvant Chemotherapy Including Non-ethanol Formulation Docetaxel Before and After Surgery",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1052,
    "primaryOutcomeMeasure": "Incidence of ethanol-induced symptoms in the initial cycle",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Those who voluntarily signed a written personal information collection and usage agreement after receiving an explanation about the objective and method, etc. of this clinical study.\n* Those are confirmed to have primary breast cancers through histological diagnosis and one of the following are applicable.\n\n  * Those who need neoadjuvant chemotherapy as breast cancer patients\n  * Those who need adjuvant chemotherapy after breast cancer surgery\n* Those who are scheduled to administer non-ethanol formulation docetaxel according to chemotherapy\n* Those able to understand this study, be cooperative in the execution of the study, and participate in the study until its completion.\n\nExclusion Criteria:\n\n* Those are diagnosed with other primary cancer that can influence the treatment or prognosis of primary breast cancers.\n* Those are diagnosed with secondary breast cancers.\n* Those with Stage 0/1 (Tis, N0, M0) or Stage IV (any T, Any N, M1) breast cancers.",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}